Multidimensional Integrated Assessment to Test the Efficacy and Response to Ozanimod in Multiple Sclerosis.

NCT05777902 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped Sponsor's decision

Conditions

Multiple Sclerosis

Interventions

DRUG: Ozanimod Oral Capsule

Sponsor

I.R.C.C.S. Fondazione Santa Lucia